 |
6-(R)-Methyl-5-O-(5-amino-5,6-dideoxy-a-L-talofuranosyl)- paromamine sulfate |
|---|---|
| Trade Name | |
| Orphan Indication | Hurler syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2016-10-18 00:00:00 |
| Sponsor | Eloxx Pharmaceuticals, Ltd.;Weizmann Science Park, 7 Golda Meir Street;Ness Ziona |
